Quick Takeaways
- GSK plc filed SCHEDULE 13D/A for CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC).
- Disclosed ownership: 0%.
- Date of event: 03 Dec 2025.
GSK plc - 03 Dec 2025 SCHEDULE 13D/A Report for CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC)
- Filing Manager
- GSK plc
- Reporting Manager
- GSK plc
- Symbol
- CVAC
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13D/A
- Filing time
- 05 Dec 2025, 16:23:32 UTC
- Date of event
- 03 Dec 2025
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GSK plc disclosed 0% ownership in CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC) on 03 Dec 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 05 Dec 2025, 16:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| GSK plc | 0% | 0 | 0 | 0 | /s/ Victoria A. Whyte | Victoria A. Whyte, Authorized Signatory | 0001131399 |